Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With Hyperuricemia

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This study is a multi-center, randomized, double-blinded, controlled trial with two parallel arms. The aim of the study is to evaluate efficacy and safety of Kui-Yuan chewable tablets in patients with hyperuricemia.
Epistemonikos ID: 7369d8c5a9f4f332fd5ad165d3a85da67da47273
First added on: Feb 19, 2024